Market Overview:
The global hemodialysis concentrates market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of renal diseases, rising geriatric population, and technological advancements in dialysis equipment and concentrates. The acid concentrates segment is expected to dominate the global hemodialysis concentrates market during the forecast period owing to its high usage in dialysis centers. However, the bicarbonate concentrates segment is projected to grow at a higher CAGR during the forecast period due its growing usage in home-based dialysis therapies. Geographically, North America dominates the global hemodialysis concentrates market followed by Europe and Asia Pacific. The growth in these regions can be attributed to factors such as increasing prevalence of renal diseases, rising geriatric population, and growing demand for home-based dialysis therapies.
Product Definition:
A hemodialysis concentrate is a sterile solution that is used to increase the fluid volume in the dialysate bath during hemodialysis. This helps to improve blood flow and remove more toxins from the blood.
Acid Concentrates:
Acid concentrates are used in hemodialysis to lower the blood pH. It is also used as a dialyzable drug for patients with end-stage renal disease and cancer. The growth factor in this market is increasing demand for acid concentrates due to technological advancements, rising prevalence of kidney failure diseases, growing R&D activities by many pharmaceutical companies and government initiatives.
Bicarbonate Concentrates:
Bicarbonate concentrates are used in hemodialysis to maintain the pH of blood and remove metabolic byproducts from it. It is also used as a coagulation modifier for blood transfusion.
Application Insights:
The market is segmented by application into dialysis center and home based care. The dialysis center held the largest share of over 70% in 2017. Dialysis centers are widely used as they offer a cost-effective solution to treat end-stage renal diseases (ESRD). In addition, the centers provide better quality of life to patients as compared with home settings.
However,homebased care is expected to grow at a rapid pace over the forecast period due largely to increasing awareness about hemodialysis among individuals living outside major cities in developing countries such as India and China. This can be attributed towards growing demand for low cost treatment options that do not require hospitalization or institutionalized setting for people who cannot access dialysis due to financial constraints or travel distance from their homes.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of kidney-related disorders, and rising preference for home hemodialysis over conventional hemodialysis. In addition, growing number of centers offering Hemodialysis is also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and rising patient awareness regarding various treatment options available for kidney diseases such as dialyze concentrate therapy.
Growth Factors:
- Increasing incidence of renal diseases: The global prevalence of chronic kidney disease is expected to increase from 9% in 2010 to 14% by 2025. This will create a large pool of patients who will require hemodialysis for treatment, thereby driving the demand for hemodialysis concentrates.
- Technological advancements in dialysis equipment: Continuous technological advancements in dialysis equipment are resulting in improved patient outcomes and reduced costs associated with hemodialysis treatment. This is likely to boost the demand for hemodialysis concentrates over the forecast period.
- Growing awareness about renal health: There is growing awareness among people about the importance of early diagnosis and treatment of renal diseases, which is likely to drive the demand for hemodialysis concentrates over the forecast period.
- creating a larger pool of patients susceptibleto chronic kidney diseases that require regulardialysistreatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemodialysis Concentrates Market Research Report
By Type
Acid Concentrates, Bicarbonate Concentrates
By Application
Dialysis Center, Home
By Companies
Fresenius Medical Care, Baxter, B. Braun, Rockwell Medical, Nipro, MEDIVATORS, Dialysis Medical Solutions, Unipharm JSC, Nikkiso, Renacon Pharma, Surni Group, Weigao Group, BIOLIGHT, Ziweishan, United Jieran, Sichuang, Sanxin, Shenyouda, Evertrust, Taishikang
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Hemodialysis Concentrates Market Report Segments:
The global Hemodialysis Concentrates market is segmented on the basis of:
Types
Acid Concentrates, Bicarbonate Concentrates
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dialysis Center, Home
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Medical Care
- Baxter
- B. Braun
- Rockwell Medical
- Nipro
- MEDIVATORS
- Dialysis Medical Solutions
- Unipharm JSC
- Nikkiso
- Renacon Pharma
- Surni Group
- Weigao Group
- BIOLIGHT
- Ziweishan
- United Jieran
- Sichuang
- Sanxin
- Shenyouda
- Evertrust
- Taishikang
Highlights of The Hemodialysis Concentrates Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acid Concentrates
- Bicarbonate Concentrates
- By Application:
- Dialysis Center
- Home
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemodialysis Concentrates Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemodialysis concentrates are a type of dialysis treatment that remove waste and excess fluid from the blood.
Some of the major companies in the hemodialysis concentrates market are Fresenius Medical Care, Baxter, B. Braun, Rockwell Medical, Nipro, MEDIVATORS, Dialysis Medical Solutions, Unipharm JSC, Nikkiso, Renacon Pharma, Surni Group, Weigao Group, BIOLIGHT, Ziweishan, United Jieran, Sichuang, Sanxin, Shenyouda, Evertrust, Taishikang.
The hemodialysis concentrates market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemodialysis Concentrates Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemodialysis Concentrates Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemodialysis Concentrates Market - Supply Chain
4.5. Global Hemodialysis Concentrates Market Forecast
4.5.1. Hemodialysis Concentrates Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemodialysis Concentrates Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemodialysis Concentrates Market Absolute $ Opportunity
5. Global Hemodialysis Concentrates Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemodialysis Concentrates Market Size and Volume Forecast by Type
5.3.1. Acid Concentrates
5.3.2. Bicarbonate Concentrates
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemodialysis Concentrates Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemodialysis Concentrates Market Size and Volume Forecast by Application
6.3.1. Dialysis Center
6.3.2. Home
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemodialysis Concentrates Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemodialysis Concentrates Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemodialysis Concentrates Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemodialysis Concentrates Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemodialysis Concentrates Demand Share Forecast, 2019-2026
9. North America Hemodialysis Concentrates Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemodialysis Concentrates Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemodialysis Concentrates Market Size and Volume Forecast by Application
9.4.1. Dialysis Center
9.4.2. Home
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemodialysis Concentrates Market Size and Volume Forecast by Type
9.7.1. Acid Concentrates
9.7.2. Bicarbonate Concentrates
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemodialysis Concentrates Demand Share Forecast, 2019-2026
10. Latin America Hemodialysis Concentrates Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemodialysis Concentrates Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemodialysis Concentrates Market Size and Volume Forecast by Application
10.4.1. Dialysis Center
10.4.2. Home
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemodialysis Concentrates Market Size and Volume Forecast by Type
10.7.1. Acid Concentrates
10.7.2. Bicarbonate Concentrates
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemodialysis Concentrates Demand Share Forecast, 2019-2026
11. Europe Hemodialysis Concentrates Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemodialysis Concentrates Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemodialysis Concentrates Market Size and Volume Forecast by Application
11.4.1. Dialysis Center
11.4.2. Home
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemodialysis Concentrates Market Size and Volume Forecast by Type
11.7.1. Acid Concentrates
11.7.2. Bicarbonate Concentrates
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectins by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemodialysis Concentrates Demand Share, 2019-2026
12. Asia Pacific Hemodialysis Concentrates Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemodialysis Concentrates Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemodialysis Concentrates Market Size and Volume Forecast by Application
12.4.1. Dialysis Center
12.4.2. Home
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemodialysis Concentrates Market Size and Volume Forecast by Type
12.7.1. Acid Concentrates
12.7.2. Bicarbonate Concentrates
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemodialysis Concentrates Demand Share, 2019-2026
13. Middle East & Africa Hemodialysis Concentrates Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemodialysis Concentrates Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemodialysis Concentrates Market Size and Volume Forecast by Application
13.4.1. Dialysis Center
13.4.2. Home
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemodialysis Concentrates Market Size and Volume Forecast by Type
13.7.1. Acid Concentrates
13.7.2. Bicarbonate Concentrates
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemodialysis Concentrates Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemodialysis Concentrates Market: Market Share Analysis
14.2. Hemodialysis Concentrates Distributors and Customers
14.3. Hemodialysis Concentrates Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fresenius Medical Care
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Rockwell Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nipro
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MEDIVATORS
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dialysis Medical Solutions
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Unipharm JSC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Nikkiso
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Renacon Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Surni Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Weigao Group
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. BIOLIGHT
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Ziweishan
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. United Jieran
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Sichuang
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Sanxin
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Shenyouda
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Evertrust
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Taishikang
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
